Comparison of the effect of two progesteron drugs in protection of abortio
Phase 3
- Conditions
- Abortion.-
- Registration Number
- IRCT20120104008611N9
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 160
Inclusion Criteria
Gestational age 6 to 13 weeks
Apearance of fetal heart rate
Uterine bleeding
Closed uterine orifice
Exclusion Criteria
Having embryonic or uterine anomalies in ultrasound
Multi fetal
Hydatidiform mole
A known underlying disease in mother
Patients who have been treated by a specific medication to treat abortion
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Abortion. Timepoint: From the start of the intervention to the 20th week of pregnancy. Method of measurement: Weekly visit.
- Secondary Outcome Measures
Name Time Method Preeclampsia. Timepoint: Up to 28 weeks monthly until 36 weeks every two weeks and thereafter weekly until delivery. Method of measurement: Mercury pressure gauge.;Gestational Diabetes. Timepoint: Up to 28 weeks monthly until 36 weeks every two weeks and thereafter weekly until delivery. Method of measurement: Glucose tolerance test.